4KO
(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Created: | 2013-05-13 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 47 |
Chiral Atom Count | 2 |
Bond Count | 49 |
Aromatic Bond Count | 5 |
Chemical Component Summary | |
---|---|
Name | (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
Synonyms | Cefmetazole |
Systematic Name (OpenEye OEToolkits) | (6R,7S)-7-[2-(cyanomethylsulfanyl)ethanoylamino]-7-methoxy-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
Formula | C15 H17 N7 O5 S3 |
Molecular Weight | 471.534 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | N#CCSCC(=O)NC3(OC)C(=O)N2C(=C(CSc1nnnn1C)CSC23)C(=O)O |
SMILES | CACTVS | 3.370 | CO[C]1(NC(=O)CSCC#N)[CH]2SCC(=C(N2C1=O)C(O)=O)CSc3nnnn3C |
SMILES | OpenEye OEToolkits | 1.7.6 | Cn1c(nnn1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O |
Canonical SMILES | CACTVS | 3.370 | CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(=C(N2C1=O)C(O)=O)CSc3nnnn3C |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1 |
InChIKey | InChI | 1.03 | SNBUBQHDYVFSQF-HIFRSBDPSA-N |
Drug Info: DrugBank
DrugBank ID | DB00274 |
---|---|
Name | Cefmetazole |
Groups |
|
Description | A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. |
Synonyms |
|
Indication | For the treatment of infections caused by susceptible organisms. |
Categories |
|
ATC-Code | J01DC09 |
CAS number | 56796-20-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Penicillin binding protein 2a | HSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNV... | unknown | inhibitor |
Penicillin-binding protein 1A | MKFVKYFLILAVCCILLGAGSIYGLYRYIEPQLPDVATLKDVRLQIPMQI... | unknown | inhibitor |
Penicillin-binding protein 1B | MAGNDREPIGRKGKPTRPVKQKVSRRRYEDDDDYDDYDDYEDEEPMPRKG... | unknown | inhibitor |
Peptidoglycan synthase FtsI | MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISP... | unknown | inhibitor |
D-alanyl-D-alanine carboxypeptidase DacA | MNTIFSARIMKRLALTTALCTAFISAAHADDLNIKTMIPGVPQIDAESYI... | unknown | inhibitor |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 42008 |
ChEMBL | CHEMBL1201195 |
ChEBI | CHEBI:3489 |